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In mammals, dosage compensation between XX
and XY individuals occurs through X chromosome
inactivation (XCI). The noncoding Xist RNA is ex-
pressed and initiates XCI only when more than one
X chromosome is present. Current models invoke a
dependency on the X-to-autosome ratio (X:A), but
molecular factors remain poorly defined. Here, we
demonstrate that molecular titration between an
X-encoded RNA and an autosomally encoded pro-
tein dictates Xist induction. In pre-XCI cells, CTCF
protein represses Xist transcription. At the onset of
XCI, Jpx RNA is upregulated, binds CTCF, and extri-
catesCTCF fromoneXist allele.We demonstrate that
CTCF is an RNA-binding protein and is titrated away
from the Xist promoter by Jpx RNA. Thus, Jpx acti-
vates Xist by evicting CTCF. The functional antago-
nism via molecular titration reveals a role for long
noncoding RNA in epigenetic regulation.INTRODUCTION
Dosage compensation balances X chromosome content
between females and males in organisms with the XY mecha-
nism of sex determination. In fruitflies, the single X chromosome
in males is transcriptionally upregulated 2-fold; in roundworms,
expression from two X chromosomes is halved in hermaphro-
dites; and in mammals, one of two X’s is transcriptionally
silenced in females during X chromosome inactivation (XCI)
(Cline and Meyer, 1996; Lucchesi et al., 2005; Payer and Lee,
2008; Wutz, 2011). Although dosage compensation is achieved
differently in various organisms, all three mechanisms depend
on the ‘‘X-to-autosome ratio’’ (X:A), which triggers the epigenetic
process only when X:A = 0.5 in fruitflies or X:A R 1.0 in round-
worms and in mammals. Failure to achieve dosage compensa-
tion results in early embryonic death. In roundworms, X-linked
factors (SEX-1, CEH-39) and autosomal signals (SEA-1, SEA-2)
antagonize each other at the master regulatory gene, xol-1
(Meyer, 2010). In fruitflies, accumulation of X signal elements(Scute, SisA, Runt, Upd) activates the master regulator Sxl,
and autosomal factors, such as Deadpan, together with nuclear
volume, oppose the X-linked signals (Barbash and Cline, 1995;
Cline and Meyer, 1996; Salz and Erickson, 2010).
In mammals, the X:A ratio currently exists only as a genetic
concept. Evidence derives from studies of aneuploids and poly-
ploids indicating that XXX females establish two inactive X’s (Xi)
when diploid but inactivate only one Xi when tetraploid; further-
more, XXX triploid females establish one or two Xi, consistent
with their intermediate X:A ratio (Brown and Chandra, 1973; Gar-
tler et al., 2006). Two conceptual frameworks have been instruc-
tive. Early thinking favored the ‘‘Blocking Factor Hypothesis,’’ in
which a single complex of autosomal factors binds to and blocks
one Xic and protects that X chromosome from silencing (Ohno,
1969; Lyon, 1971; Kay et al., 1994; Starmer and Magnuson,
2009). Remaining Xs are unprotected and become silenced by
default. The alternative ‘‘Two Factors Model’’ postulates the ex-
istence of not only a blocking factor to protect one X but also a
‘‘competence factor’’ to trigger silencing on additional Xs (Gartler
and Riggs, 1983; Lee and Lu, 1999; Lee, 2005). Thus, regardless
of details, all current models imply a molecular titration of
X-linked and autosomal factors.
Consistent with their separate evolution, fly and worm regula-
tors are not apparently utilized in the mouse. Unlike the inverte-
brate systems, mammalian dosage compensation is allelically
controlled and involves regulatory switches defined by long non-
coding RNA (lncRNA) within the master ‘‘X-inactivation center’’
(Xic). Xist RNA emanates from the Xic, coats the future Xi in
cis, and deposits silencing complexes along the chromosome
(Brockdorff et al., 1992; Brown et al., 1992). Xist is expressed
only when X:A R1.0, and the number of Xist RNA foci follows
the ‘‘n-1’’ rule in diploid cells (n = X chromosome number).
Recent work shows that Xist is both negatively and positively
regulated. It is repressed by the antisense Tsix RNA and the non-
coding Xite locus (Lee and Lu, 1999; Sado et al., 2001; Ogawa
and Lee, 2003) but activated by the long noncoding Jpx RNA
(Tian et al., 2010) and the E3 ubiquitin ligase, RNF12 (Jonkers
et al., 2009) (Figure 1A).
The identities of X-encoded ‘‘numerators’’ and autosomally
encoded ‘‘denominators’’ of the X:A ratio have been elusive. In
principle, X-linked and autosomal regulators must converge
at the Xic—potentially at the Tsix, Xite, or Xist locus. Indeed,Cell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc. 1537
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integrating extra Xic copies into either a male or female genome
mimics the presence of supernumerary Xs and triggers ectopic
XCI (reviewed in Starmer and Magnuson, 2009; Lee, 2011).
One study implicated the Tsix/Xite loci as binding sites for de-
nominators without identifying specific autosomal factors (Lee,
2005). Another study showed that XCI is sensitive to dosage of
autosomal OCT4 protein (Donohoe et al., 2009). The X-encoded
E3 ubiquitin ligase, RNF12, was also proposed as a candidate
numerator, as excess RNF12 triggers ectopic Xist expression
(Jonkers et al., 2009) and RNF12-mediated ubiquitylation of
REX1 occurs at the initiation of XCI (Gontan et al., 2012).
RNF12’s candidacy as numerator may be complicated by its
catalytic nature, however. The necessity of precise X:A titration
renders catalytic factors conceptually problematic because cat-
alytic factors with rapid enzymatic rates are unlikely to be limited
by 2-fold molar differences. Indeed, deleting a single allele of
Rnf12—a state that mimics the XY state—delayed but did not
abrogate Xist upregulation in mice (Jonkers et al., 2009; Shin
et al., 2010; Barakat et al., 2011).
In molecular titration models, numerators are more easily en-
visioned as stoichiometric than as catalytic factors. Candidate
numerators must in theory satisfy several experimental criteria.
First, it must be X-linked and escape XCI in order to provide
numerical information. Second, it should elicit discrete XCI phe-
notypes in response to changes in gene copy number. It must
also be haploinsufficient, with the +/ state phenocopying the
male state; overexpression should simulate supernumerary X’s
and trigger ectopic XCI. Finally, the numerator must act at the
Xic. Intriguingly, the noncoding Jpx/Enox gene resides 10 kb
upstream of Xist (Chureau et al., 2002; Johnston et al., 2002;
Chow et al., 2003), escapes XCI, and is required for Xist activa-
tion (Tian et al., 2010). Deleting a single Jpx allele in female cells
is sufficient to prevent XCI (Tian et al., 2010). This haploinsuffi-
ciency and its escape from XCI raises the intriguing possibility
that Jpx RNA may be a numerator. Below, we subject Jpx to
the test and define interactions that implicate Jpx in molecular
titration of an autosomal factor.
RESULTS
Jpx Induces Xist in a Dose-Dependent Manner
To determine if altering Jpx levels results in quantifiable changes
ofXist expression, we introduced a 90 kb Jpx transgene (Tg(Jpx);
Figure 1B) into wild-type male and female mouse embryonic
stem (ES) cells, a well-established ex vivo model that recapitu-Figure 1. Jpx Overexpression Results in Ectopic Xist Upregulation
(A) Positive-negative regulation of Xist. Arrows, activation; blunt arrows, repressi
(B) Map of Xic, FISH probes, and Jpx transgenes. Tg(Jpx).
(C) Quantitation of Jpx and Xist expression on d4 in Tg(Jpx) ES cells by qRT-PCR
Expression levels normalized to ctrl (control clone). Averages ± SE. See also Fig
(D) Xist expression examined by RNA-DNA FISH in d4 ES cells. FITC (green, pr
insertion site.
(E) Quantitation of Xist RNA-DNA FISH results in d4 ES cells. Representative clo
(F) Disabling Tsix augments Xist’s response to Jpx overexpression. RNA-DNA FIS
One representative clone shown for each. FITC (green, probe 1), Xist RNA cloud
(G) Quantitation of cells (in F) with the Xist pattern indicated.
(H) qRT-PCR of Xist and Jpx RNA levels on d4, normalized to RNA levels in pare
See also Figure S1.lates XCI during cell differentiation. Quantitative RT-PCR
confirmed overexpression of Jpx RNA between 0.5- to 2-fold
in multiple independent clones on day 4 of differentiation (d4;
Figure 1C), and RNA-DNA fluorescence in situ hybridization
(FISH) showed ectopic Xist clouds in differentiating embryonic
stem (ES) cells at d4 (Figures 1D and 1E). Consistent with
elevated steady-state levels of Xist shown by qRT-PCR (Fig-
ure 1C), 1%–4% of transgenic male cells possessed an Xist
cloud, and 1%–2% of diploid female cells exhibited a second
Xist cloud. (Note: tetraploid cells were excluded by performing
DNA FISH using probe 2; Figure 1D.) Ectopic Xist clouds were
neither observed in control male nor female cells carrying vector
sequences (ctrl). Thus, whereas reducing Jpx expression by half
blocks Xist activation (Tian et al., 2010), 2-fold overexpression of
Jpx caused ectopic Xist expression.
Themagnitude of overexpression was, however, small. Noting
a general correlation between Jpx levels and degree of Xist up-
regulation (Figures 1C–1E), we asked if increasing Jpx overex-
pression caused greater Xist induction. By retrofitting the strong
Elongation Factor 1a (EF1a) promoter into the Jpx transgene
(Tg(EF1a:Jpx); Figure 1B), we further enhanced Jpx activity
and observed greater Xist induction. RNA-DNA FISH indicated
that up to 7% of cells displayed two Xist clouds (Figures 1D
and 1E). Correlation of Jpx and Xist overexpression was also
observed in later stages of differentiation (Figure S1A available
online; data not shown). Xist expression therefore shows a
dose-dependent response to Jpx expression.
Deleting Tsix Augments Jpx’s Effect
The transgene experiments showed that, although the number of
Xist clouds (10%–14%) was consistently elevated with Jpx over-
expression, the percentage of ectopic Xist clouds never ex-
ceeded 7%. We recalled that Tsix and Jpx dually regulate Xist
expression (Tian et al., 2010), with Xist being difficult to induce
when the Tsix allele in cis is intact (Luikenhuis et al., 2001; Stav-
ropoulos et al., 2001). During female differentiation, Tsix’s
repression on the future Xi enables Xist upregulation, whereas
its persistent expression on the future Xa blocks Xist induction.
Likewise, duringmale differentiation, persistent Tsix on the single
X chromosome prevents Xist expression. Therefore, could an
intact Tsix allele blunt the effect of Jpx overexpression in the
Jpx transgenic male and female cells?
To address this, we introduced Tg(EF1a:Jpx) into ES cells
carrying a truncated Tsix allele (TsixTST) (Ogawa et al., 2008)
and observed that disabling Tsix increased susceptibility toon.
. Representative independent clones (male Bs2, B2; female E2, E1) are shown.
ure S1.
obe 1), Xist RNA cloud. Cy3 (red), BAC5 probe 2 marks Xic. Arrowheads, Tg
nes shown. n, sample size. See also Figure S1.
H of Tg(EF1a:Jpx) cells in a TsixTST/Y or TsixTST/+ cells on d4 of differentiation.
. Cy3 (red), BAC5 probe 2 marks Xic. Arrowheads, Tg insertion site.
ntal TsixTST/Y or TsixTST/+ cells. Averages ± SE.
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Jpx overexpression (Figures 1F and 1G). In male cells, the num-
ber of ectopic Xist clouds increased from 1%–4% in a wild-type
background (Figure 1E) to 7.7% in the TsixTST/Y background
(JTB1). The percentage further increased to 15.4% when Jpx
was overexpressed from the EF1a promoter in the TsixTST/Y
background (JTF4) (Figure 1G; c2 one-tailed, p = 0.01). In female
cells, Tsix deficiency increased ectopic Xist clouds from 1% in
a wild-type background (Figure 1E) to 12.2% in the TsixTST/+
background (ETB1). The percentage further increased to
12.9% when Jpx was overexpressed from the EF1a promoter
(ETF2) (Figure 1G; c2 one-tailed, p < 0.05). (The effect in females
was less than in males, likely because Tsix remained intact on
one female X; nonetheless, persistent Tsix allele on the future
Xa would eventually be downregulated during differentiation,
providing an opportunity for Jpx overexpression to act on the
newly susceptible Xa, resulting in cells with two Xist clouds.)
qRT-PCR showed a further 2-fold increase in Xist levels
when Jpx is overexpressed from the EF1a promoter after trun-
cating Tsix in female cells; in male cells, an even larger increase
in Xist was observed (Figure 1H).
We conclude that the dose-dependent response of Xist to Jpx
levels is augmented by deleting Tsix, consistent with the notion
that Xist is coregulated by a Jpx-based positive pathway and a
Tsix-based negative pathway (Lee and Lu, 1999; Sado et al.,
2001; Tian et al., 2010). The presence of intact Tsix may explain
why Jpx transgenic overexpression in previous studies did not
result in ectopic Xist induction (Augui et al., 2011; Barakat
et al., 2011).
CTCF Binds the Xist Promoter and Correlates with Xist
Repression
Xist is known to be regulated at the transcriptional level (Sun
et al., 2006). Within a 3 kb promoter region of Xist, three binding
sites for the zinc finger protein, CTCF (Bell et al., 1999; Ohlsson
et al., 2001), have been proposed, including one upstream of
mouse Xist (Xist_50; Navarro et al., 2006), one at human XIST’s
first promoter (P1; Pugacheva et al., 2005), and one at promoter
P2 in mice (Sheardown et al., 1997; Navarro et al., 2006; Essien
et al., 2009) (Figure 2A). One study reported a positive correlation
between Xist activation and affinity of P1 for CTCF (Pugacheva
et al., 2005). Another study proposed CTCF as chromatin insu-
lator for P1 (Navarro et al., 2006). To pinpoint CTCF’s role, we
asked if CTCF directly binds the threemurine sites by performing
electrophoretic mobility shift analysis (EMSA). Whereas a GFP
control did not shift any probe, purified CTCF strongly shifted
Xist_50 and P2 (Figure 2B). By contrast, CTCF did not shift P1,
a site lacking the CTCF consensus motif (Essien et al., 2009).
The shift was as robust as that observed for the strong bindingFigure 2. CTCF Binding to the Xist Promoter Is Anticorrelated with Xis
(A) Xist P1 and P2 promoters, CTCF sites, and EMSA probes. Red, CTCFmotif. G
(B) DNA EMSA using indicated probes with recombinant CTCF or GFP protein. *
(C) CTCF ChIP quantitative PCR analysis on d0, d3, and d6 ES cells as indicat
independent experiments were performed for each time point. Averages ± SE.
(D) Allele-specific ChIP for CTCF at Xist P2 site in TsixTST/+ female ES cells. cas,
were performed for each time point. Averages ± SE.
(E) CTCF ChIP on d0, d3, and d6 female Jpx+/ ES cells. Three independent ex
P, one-way t test comparing d0 versus d3 and d6 for each site.site at RS14c, a Tsix-Xist boundary element at Xist’s 30 end
(Spencer et al., 2011). Mutating three nucleotides in the
consensus motif abolished the shift (Figures 2A and 2B). We
conclude that CTCF directly binds Xist_50 and P2 in vitro.
To test binding in vivo, we carried out quantitative chromatin
immunoprecipitation (ChIP) for CTCF in male and female ES
cells. In undifferentiated (d0) male and female cells, CTCF occu-
pied Xist_50 and P2 (Figure 2C), consistent with EMSA results.
Although CTCF could not bind P1 in the gel shift analysis, occu-
pancy was observed by ChIP, suggesting that CTCF occupancy
at P1 could be mediated by other factors in vivo. One possibility
is that chromatin looping from P2 brought CTCF in proximity to
P1. During differentiation, CTCF enrichment at all three sites re-
mained unchanged in male cells. However, in female cells, bind-
ing to P2 was significantly reduced (p = 0.008) by approximately
half between d0 and d6 (Figure 2C), the time frame of Xist upre-
gulation. Enrichment at P1 was similarly decreased (but with
borderline significance; p = 0.17), consistent with the idea of
CTCF looping in from P2. Binding to positive control regions,
RS14c and H19, and a negative control, Rnf12, was unaltered
during this time frame. These results demonstrate that CTCF
binding to P2 is dynamically regulated during XCI.
Given 2-fold changes in P2 binding, we suspected allelic dif-
ferences. To test the possibility of differential binding to Xa and
Xi, we performed allele-specific ChIP quantitative PCR in a
genetically marked female ES line, TsixTST/+. In this cell line, a
Tsix truncation on the Mus musculus (mus) X chromosome en-
sures that this chromosome will be Xi and the Mus castaneus
(cas) X chromosomewill be Xa (Ogawa et al., 2008); a strain-spe-
cific polymorphism located 200 bp downstream of P2 (Keane
et al., 2011) enabled allelic discrimination by PCR. Indeed,
CTCF occupancy was significantly reduced at P2 of the future
Xi (Figure 2D), linking the loss of CTCF binding with Xist activa-
tion. In the Jpx+/ haploinsufficient ES cell line (Tian et al.,
2010), the inability to upregulate Xist during differentiation corre-
latedwith persistent binding of CTCF to P2 (Figure 2E). Together,
these data show that CTCF binding to Xist P2 is allelically regu-
lated and is anticorrelated with Xist expression.
CTCF Is a Blocking Factor for Xist Upregulation
Anticorrelation of CTCF binding and Xist upregulation suggests
that CTCF serves as an Xist repressor. To test this, we overex-
pressed CTCF in male and female ES cells by creating stable
transgenic lines carrying a doxycycline(dox)-inducible bidirec-
tional TRE promoter that, when induced, simultaneously ex-
presses FLAG-tagged CTCF and a GFP marker (Figure 3A). At
least two independent transgenic male and female clones were
analyzed, and representative results are shown. Induction wast Expression
reen bases, nonconforming CTCF motif. Blue, mutated bases in EMSA probes.
, DNA-protein shift.
ed. Rnf12, negative control; RS14c and H19, positive controls. At least three
M. castaneus. mus, M. musculus. Two independent experiments in triplicates
periments were performed for each time point. Averages ± SE.
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Figure 3. CTCF Overexpression Results in Female-Specific EB Outgrowth Defect
(A) Dox-inducible bidirectional expression of CTCF-3xFLAG and GFP in rtTA-expressing MEF. Normal cell morphology shown by phase-contrast before (Dox)
and after (Dox+) induction of GFP and CTCF. FLAG and CTCF immunofluorescence shown.
(B) Western blot of representative transgenic clones shows dox-induction of CTCF-3xFLAG in d0 ES cells (left panel) and d1 female ES cells (right panel).
(C) CTCF overexpression results in female-specific defect in outgrowth up to d13. Bright field images show EB outgrowth. GFP indicates transgene (CTCF)
overexpression. Note GFP-positive cells in male, but not female, outgrowth in Dox+ condition. After induction, GFP signals are confined to the EB center.
(D) Female control, ctrl#5, carries a silenced transgene and grows normally, whereas overexpressers, clones #2 and #1, fail to outgrow. d5 images shown.tightly regulated by dox and not obviously toxic (Figures 3A and
3B). In male clones (e.g., #11), CTCF overexpression revealed
no phenotype between d0 to d11, as embryoid bodies (EB)
outgrowth was robust (Figure 3C). By contrast, CTCF overex-1542 Cell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc.pression in female clones (e.g., #1, #2) caused severe outgrowth
defects after differentiation (Figures 3C and 3D). GFP+ (CTCF+)
cells were confined to the EB center, whereas outgrown cells
were GFP (CTCF), implying viability only when the transgene
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Figure 4. CTCF Overexpression Inhibits Xist Induction in a Temporally Sensitive Manner
(A) CTCF overexpression blocks Xist upregulation. Left panel: RNA-DNA FISH on d6 female transgenic cells ±Dox. Green, Xist RNA. Red, Xic locus. Middle panel:
Quantitation of Xist clouds ± Dox on d6 for two clones. Only full Xist clouds are scored (not pinpoint signals). Right panel: qRT-PCR on d4 cells for Oct4, Bmp4,
and Xist RNA. Averages ± SE.
(B) Sensitive time window between d2–d4 of EB differentiation. Dox is applied on the days indicated (red bar) during time course analysis. Phase contrast and
corresponding GFP images are shown for d11.was silenced. Defects were strictly correlated with CTCF overex-
pression, as transgenic female clones without overexpression
(e.g., #5) showed no growth anomalies (Figure 3D). We conclude
that CTCF overexpression is toxic specifically to female cells
during differentiation, consistent with an effect on XCI.We next performed Xist RNA-DNA FISH and found that CTCF-
overexpression significantly affected Xist upregulation. Whereas
37%–43% of uninduced cells displayed full Xist clouds by d6,
only 7%–8% of CTCF-overexpressing cells showed robust Xist
clouds (Figure 4A). Quantitative RT-PCR confirmed a failure toCell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc. 1543
fully upregulate Xist, despite progression through cell differenti-
ation as indicated by normal levels of Oct4 andBmp4messenger
RNA (mRNA) (Figure 4A). Collectively, these findings demon-
strate that CTCF overexpression blunts Xist upregulation and
argue that CTCF is a blocking factor for Xist. The proposed
repressive effect of CTCF is consistent with the observation
that knocking down CTCF results in Xist upregulation (Donohoe
et al., 2007).
We then asked if CTCF’s effects were restricted to the devel-
opmental window of Xist upregulation. To perform a time course
analysis, we applied dox at various time intervals and observed
large differences in relation to specific periods of induction (Fig-
ure 4B). As expected, dox induction between d0–d11 caused
scant EB outgrowths, whereas untreated EB exhibited robust
outgrowth. When dox was applied only between d0–d2,
outgrowth was slow to appear but recovered during the dox-
free interval. When treatment was extended to d0–d4 or applied
between d2–d11, outgrowth was severely restricted and never
recovered. On the other hand, dox treatment after d4 had no
effect. Thus, female ES cells are sensitive to CTCF overexpres-
sion only between d0 and d4, most acutely between d2–d4,
the time frame corresponding to the initiation of XCI.
Jpx RNA Titrates CTCF Binding
The fact that CTCF persisted at XistP2when Jpx is deficient (Fig-
ure 2E) hinted that CTCF and Jpx may be antagonistically linked.
We asked if overexpressing Jpx could relieve the effect of CTCF
overexpression by introducing the EF1a:Jpx transgene into
CTCF-overexpressing female cells (Tg(EF1a:Jpx)/Tg(TRE:Ctcf)).
Indeed, the outgrowth defect was reversed (Figure 5A, note
GFP+ outgrowth), and normal numbers of full Xist clouds were
restored, from 3% to 36% (Figure 5B). qRT-PCR and western
analysis confirmed Jpx and CTCF overexpression (Figures 5C
and 5D). An antagonistic relationship between Jpx and CTCF
was also evident from 2-fold decreases in Xist levels when
CTCF alone was overexpressed (Figure 5C); when Jpx alone
was overexpressed, Xist levels increased 2-fold; and, finally,
whenCTCF and Jpxwere both overexpressed, Xist was restored
to wild-type levels. Therefore, Xist defects due to CTCF overex-
pression could be overcome by expressing more Jpx. These
data indicate that Xist is controlled by a balance of Jpx and
CTCF and that Jpx antagonizes CTCF by titrating CTCF’s
repressive effect on Xist.
Jpx RNA Binds CTCF
To understand the mechanism of titration, we asked if Jpx RNA
and CTCF interact in vivo by performing UV crosslinked RNA
immunoprecipitation (UV-RIP) with anti-FLAG antibodies in d12
female ES cells (Figure 6A). Jpx RNA showed significant coim-
munoprecipitation with FLAG-CTCF, whereas cyclophilin and
Xist RNAdid not.WhenRIPwas performedwithout UV crosslink-
ing, Jpx enrichment was not observed, demonstrating that strin-
gent conditions enabled RNA pull-down only when Jpx and
CTCF were crosslinked. Given that UV crosslinks RNA to protein
only when in direct contact, these data suggest that Jpx directly
interacts with CTCF in vivo.
We then investigated Jpx-CTCF interactions in vitro. RNA pull-
down assays using purified FLAG-CTCF showed that CTCF pref-1544 Cell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc.erentially interacted with Jpx RNA among total cellular RNA
extracted from female MEF (Figure 6B). Conversely, Jpx RNA
preferentially bound CTCF over control FLAG-GFP. Increasing
CTCF levels resulted in greater pull-down of Jpx RNA, demon-
strating that the CTCF-Jpx interaction is dose dependent. Jpx
RNA has a number of alternative splice forms (Chureau et al.,
2002; Johnston et al., 2002; Chow et al., 2003), but genetic anal-
ysis indicates that only the region spanning exons 1–3 (E1–E3) is
required for function (Lee et al., 1999). In an electrophoretic
mobility shift assay (EMSA) using purified recombinant protein,
the 383 nt E1–E3 isoform of Jpx was robustly shifted by CTCF,
but not GFP (Figure 6C). Increasing CTCF resulted in greater
binding to Jpx but not an Xist RNA control of the same size,
indicating a specific, direct, and dose-dependent interaction
between CTCF and Jpx. The strong shift required full-length
E1–E3, as CTCF only weakly shifted E1–E2 and E2–E3 isoforms
(Figure 6D). We conclude that CTCF directly binds Jpx RNA.
Jpx Activates the Xist Promoter by Titrating Away CTCF
Binding
The physical interaction (Figures 6A–6D) and opposing effects
(Figure 5) of Jpx and CTCF raised the possibility that Jpx could
titrate CTCF from Xist P2 and, in so doing, activate Xist. Interest-
ingly, EMSA revealed that Jpx RNA and P2 DNA compete for
binding to CTCF. In an RNA EMSA, the Jpx-CTCF shift was
diminished by adding cold P2 DNA (Figure 6E). This effect was
attenuated by mutating the P2 DNA competitor. In the reciprocal
DNA EMSA, the P2-CTCF shift was progressively titrated away
by increasing amounts of Jpx RNA (Figure 6F, left panel), with
intact E1–E3 being required for maximal effect (Figure 6F, right
panel). Thus, Jpx RNA and P2 DNA compete for CTCF binding.
To determine whether the competition results in titration of
CTCF-P2 binding in vivo, we performed CTCF ChIP at the Xist
promoter and asked how CTCF binding is affected by Jpx or
CTCF levels (Figure 7A). When CTCF alone was overexpressed,
P2 binding was significantly boosted (red) and Xist upregulation
was compromised (Figures 4A and 5B). When Jpx alone was
overexpressed, CTCF binding at P2 was reduced approximately
by half (green), consistent with titration at one Xist allele and
ectopic Xist upregulation (Figure 1). When Jpx and CTCF were
overexpressed together (purple), P2 binding was restored.
Therefore, Jpx indeed titrates CTCF binding at the Xist P2
promoter.
To investigate how the CTCF-Jpx titration affects Xist pro-
moter activity, we carried out luciferase (Luc) reporter assays
after modulating CTCF and Jpx levels (Figure 7B). Luciferase
constructs fused to P1 and/or P2 were introduced into female
ES cells and tested during differentiation when Jpx levels nor-
mally rise. When introduced into Jpx+/ females, luciferase
expression was reduced to half that of wild-type (WT) females
(Figure 7B, left panel, black versus red), consistent with
Jpx+/ cells being male-like and incapable of supporting Xist
upregulation. This defect was overcome by transgenically ex-
pressing Jpx RNA (Figure 7B, middle panel). This rescue
depended on an intact P2 promoter, as mutating P2 abolished
the rescue (P2mut; red versus purple). Finally, Xist promoter
activity was repressed by CTCF overexpression (Figure 7B,
right panel, black versus green), and the repression could be
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(A) Overexpressing Jpx RNA rescues outgrowth defects caused by CTCF overexpression. Phase contrast and corresponding GFP signals shown on d8 of
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(D) CTCF-FLAG induction shown by western blotting.
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Compare lanes marked by red arrows.overcome by mutating P2 (green versus purple). Although the
effects were statistically significant with P2 alone (1 kb), the
combination of P1+P2 (2 kb) was more robust, suggesting that1546 Cell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc.P1 and P2 together enabled full regulation. We conclude that
competitive interactions between CTCF, Jpx RNA, and the Xist
promoter regulate Xist transcriptional induction.
DISCUSSION
We have shown that Xist transcription is controlled by a dynamic
balance of CTCF and Jpx RNA. Our data argue that CTCF is a
blocking factor for the Xist promoter, that promoter blockage is
relieved by Jpx-mediated eviction of CTCF, and that promoter
P2 is the primary site of action. Jpx meets several conceptual
criteria for a numerator of the X:A ratio. Jpx resides at the Xic
and escapes XCI (Chureau et al., 2002; Johnston et al., 2002;
Chow et al., 2003; Tian et al., 2010). Jpx RNA is also diffusible
and trans-acting (Tian et al., 2010), two properties that facilitate
titration. Moreover, Jpx RNA acts directly at the Xic, specifically
at the Xist promoter, where it titrates away CTCF to induce Xist
transcription.
The titration model centered on Jpx-CTCF-P2 interactions is
supported by experimental observations (summarized in Fig-
ure 7C). In wild-type cells, Jpx is expressed at 2-fold greater
levels in female cells than in male cells (Figure S1B). Deleting a
single allele of Jpx in females abolishes Xist upregulation and
simulates the XY state (Tian et al., 2010). Conversely, overex-
pressing Jpx induces ectopic Xist expression, mimicking the
presence of additional X chromosomes. Modulating levels of
the autosomal factor, CTCF, likewise affects Xist induction.
Overexpressing CTCF blocks Xist activation, but this blockage
is overcome by increasing Jpx RNA levels. Conversely, ectopic
Xist activation caused by Jpx overexpression is blunted by over-
expressing CTCF. Furthermore, Xist promoter repression by
CTCF cannot be relieved in Jpx+/ cells, but the defect is
rescued by exogenous Jpx.
Some curious aspects of our findings are the locus-specific
and allelic nature of the Jpx-CTCF-P2 interactions. Because
CTCF is ubiquitous, specificity for P2 binding must involve addi-
tional factors and proper context. Similarly, Jpx’s exclusivity for
CTCF bound to P2 must be influenced by proper context.
Furthermore, the monoallelic nature of the titration under physi-
ological conditions is likely linked to the X:A ratio. We suggest
that Jpx is a component of the competence factor proposed in
the Two Factors Model, which postulates that—in addition to
an autosomal blocking factor—an X-linked competence factor
arises only when X:A R1.0 and is essential for inducing Xist
(Lee and Lu, 1999; Lee, 2005). Our data suggest that CTCF is
a denominator and subunit of the blocking factor. In support of
this, overexpression blocks Xist P2 activity, knockdown results
in increased Xist expression (Donohoe et al., 2007), and binding
to P2 is anticorrelated with Xist expression. In our model, the
Jpx:CTCF ratio induces Xist transcription only when a critical
threshold is exceeded (Figures 7E and 7F). When expressed
from a single X (XY state), Jpx concentrations fail to reach
threshold. When expressed from two X’s (XX state), Jpx concen-
trations exceed threshold and result in extrication of CTCF from
one Xist allele. Overexpression of Jpx (e.g., in XXX or Tg(Jpx)
cells) would result in crossing of a second threshold, leading to
eviction of CTCF from both Xist promoters and to biallelic Xist
activation.
The all-or-none dynamics of this type of stoichiometric inter-
action would require a robust ‘‘biphasic switch,’’ as proposed
for other bimodal gene expression responses (Cline and Meyer,
1996; Ptashne, 2011; Gutierrez et al., 2012). Nonlinear dynamics,such as those resulting from highly cooperative interactions,
would be a necessary property of the Jpx-CTCF-P2 interactions.
Nonlinear dynamics enable small changes in factor concentra-
tion to elicit large biological effects (e.g., all-or-none binding
and transcription induction) in a way that is not possible with
linear dynamics (Figure 7F). This concept is exemplified by the
classic biphasic switch of lambda phage. The all-or-none effects
of cro activation is based on cooperative binding of multiple l
repressors to three operators within the cro promoter (Ptashne,
2011). At the 50 end of Xist, multiple sites for CTCF and other fac-
tors (e.g., YY1) occur, though the potential for coooperativity has
not been tested.
Long noted for an abundance of lncRNA, the Xic is now known
to regulate XCI through a series of RNA-protein interactions (Lee,
2011). In addition to Xist-Polycomb (Zhao et al., 2008) and Xist-
YY1 interactions (Jeon and Lee, 2011) for the initiation of
silencing, here we have uncovered Jpx-CTCF interactions for
molecular titration. Like YY1, CTCF is a ‘‘bivalent’’ protein,
capable of binding both RNA and DNA. Interestingly, CTCF was
previously found to be in a larger complex containing SRA (Yao
et al., 2010). Perhaps, bivalency of other chromatin factors will
also emerge in time as key determinants of epigenetic regulation.
EXPERIMENTAL PROCEDURES
Transgenic ES Cell Lines
Tg(Jpx) and Tg(EF1a:Jpx) containing full-length Jpx and Neo marker were
made by ET-cloning (Yang and Seed, 2003) from BAC 399K20 and pEF1/
V5-His vector (Invitrogen). The Neo vector was used as control. For bidirec-
tional inducible CTCF and EGFP expression, a Hygro cassette flanked by
SV40 promoter and polyA was inserted into pTRE-Tight-Bi (Clontech) using
PciI; EGFP was inserted using BglII; 3xFLAG cassette was inserted into
NotI-SalI sites; and CTCF complementary DNA (cDNA) was cloned in-frame
using MluI and NotI. Wild-type J1 male and 16.7 female ES cells (Lee and
Lu, 1999) and TsixTST/Y and TsixTST/+ ES cells (Ogawa and Lee, 2003) have
been described previously. Ainv15 male ES cells carrying the tet-activator
rtTA were a gift from G. Daley (Kyba et al., 2002). F1-2.1 female ES cells car-
rying rtTA were a gift from R. Jaenisch (Luikenhuis et al., 2001). Transgenic ES
cells were generated by electroporation (Bio-Rad Genepulser) with stable
clones picked after 8–11 days under G418 (400 mg/ml), hygromycin B
(200 mg/ml), or puromycin (1 mg/ml) selection. Autosomal integration was
confirmed by DNA FISH. Doxycycline induction was performed at 1 mg/ml.
RNA/DNA FISH and Immunostaining
Simultaneous RNA-DNA FISH has been described previously (Lee and Lu,
1999). Immuno-FISH was performed as described previously (Zhang et al.,
2007). Cells were blocked with PBS, 0.2% Tween20, and 1% BSA. Anti-
CTCF (Cell Signaling D31H2) and anti-FLAG M2 (Sigma F1804) were diluted
1:1,000 and incubated at room temperature for 1–2 hr.
qRT-PCR
Total RNA was extracted using TRIzol (Invitrogen), treated with TURBO DNase
(Ambion), and reverse transcribed using SuperScript III (Invitrogen) and
random primers (Promega). Quantitative PCR was performed using iQ SYBR
Green Supermix on a CFX96 (Bio-Rad). PCR primers are as follows.
Jpx: e1-F and e1-R (Tian et al., 2010); mJpx76+(ex1), 50-TTAGCCA
GGCAGCTAGAGGA-30, and mJpx225-(ex2), AGCCGTATTCCTCCATGGTT.
Xist: NS33 and NS66 (Stavropoulos et al., 2001). Oct4: BD151 GGACAT
GAAAGCCCTGCAGAAGG and BD152 CGAAGCGACAGATGGTGGTCTGGC.
Bmp4: BD172 CTGGACACCTCATCACACGACTACTGG and BD173 GGG
CCCAATCTCCACTCCCTTGAGG. Ctcf: BD79 ATCGTAgctagcATGGAAGGT
GAGGCGGTTGAAGCC and BD6 tgacatcctggaccacctcaccc. Gapdh: Gapdh
F and R (Jeon and Lee, 2011).Cell 153, 1537–1551, June 20, 2013 ª2013 Elsevier Inc. 1547
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In Jpx+/- cells, CTCF-P2 binding cannot be relieved, but is overcome by Jpx overexpression [Fig. 2E].
Escape from XCI Jpx fully escapes XCI [Chureau et al., 2002; Johnston et al., 2002; Chow et al., 2003; Tian et al., 2010] 
Jpx relieves CTCF repression of Xist transcription in vivo [Luc assay, RNA FISH - Fig. 7B,5].   
Jpx binds and molecularly titrates CTCF [RIP, competitive EMSA - Fig.6].
Overexpressing Jpx causes ectopic Xist activation, but ovexpressing CTCF blunts effect.
(legend on next page)
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FLAG-CTCF and FLAG-GFP Purification
Ctcf orGFP cDNA (pFA6a-GFP(S65T)-kanMX6) with C-terminal 6xHis tag was
cloned into pFLAG-2 (Sigma-Aldrich) using EcoRI and XhoI. FLAG-CTCF-
6xHis and FLAG-GFP-6xHis proteins were purified from Rosetta-Gami B cells
(Novagen). Briefly, cells were induced with 0.2 mM IPTG at 18C (CTCF) or
1 mM IPTG (GFP) at 30C and lysed at 4C with 50 mM sodium phosphate
(pH 8.0), 300 mM NaCl, 20 mM imidazole, 0.5% Sarkosyl, and protease inhib-
itors. Triton X-100 was added to 2% final [v/v]; debris was removed by centri-
fugation; and proteins were eluted from Ni-NTA resin (QIAGEN) with 50 mM
sodium phosphate (pH 8.0), 300 mM NaCl, and 250 mM imidazole. Eluates
were dialyzed against 50 mM Tris-HCl (pH 7.5), 2.5 mM MgCl2, 150 mM
NaCl, 0.1 mM ZnSO4, 1 mM DTT, 0.1% Tween-20, and 10% glycerol.
DNA and RNA EMSA
For DNA EMASA, these double-stranded 80-mer DNA oligonucleotides were
used:
Xist_50: TTTGGCTTCAGATGCCTTGGAAAGATTCATGCTGCCACCTGCTG
GTTTATTCAGTCTGTGTGCATCATTTATTTACTTGT; Xist_50mut:
TTTGGCTTCAGATGCCTTGGAAAGATTCATGCTGCTACTTGCTAGTTTAT
TCAGTCTGTGTGCATCATTTATTTACTTGT; P1:
TTGTGGCCACTCCTCTTCTGGTCTCTCCGCCTTCAGCGCCGCGGATCA
GTTAAAGGCGTGCAACGGCTTGCTCCAGCCAT; P2:
GAATGTGTCTAAGATGGCGGAAGTCATGTGACCTGCCCTCTAGTGGTTT
CTTTCAGTGATTTTTTTTTTGGCGGGCTTTA; P2 mut:
GAATGTGTCTAAGATGGCGGAAGTCATGTGACCTGTCCTATAGTTGTTTC
TTTCAGTGATTTTTTTTTTGGCGGGCTTTA; and
RS14C: CTATGCATTAGGTTTGGGTGTTATACCCGTGTAGGCCAGCAGA
GGGTGTCGGATCCCAAGGAAACCAAGTTACAGACGCC.
To anneal forward and reverse strands, oligos were heated to 95C and
slow-cooled to room temperature in 10 mM Tris-HCl (pH 8.3), 1.5 mM
MgCl2, and 50 mM KCl. Double-stranded DNA probes were end-labeled
with ATP[g-32P] and unincorporated ATP removed with Microspin G-50
columns (GE Healthcare). A 2 pmol of recombinant proteins were incubated
at room temperature (RT) with 1 pmol of probes in 1 mg poly dI-dC, 50 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl2, 0.1 mM ZnSO4, 1 mM DTT,
10% glycerol, and 0.1% Tween-20. Samples were resolved at RT by TBE-
6% or 7% PAGE gel.
RNA EMSA was performed as described previously (Cifuentes-Rojas et al.,
2011). RNA probe was in vitro transcribed with T7 RNA polymerase (Ambion)
off PCR-amplified cDNA templates created using
T7_Jpx_ex1F, TAATACGACTCACTATAGACGGCACCACCAGGCTTCT;
Jpx_ex3R, GAGTTTATTTGGGCTTACAGTTC (Johnston et al., 2002);
Jpx_ex2R, AGCCGTATTCCTCCATGGTT; T7_Jpx_ex2F, TAATACGACTCAC
TATAGAACCATGGAGGAATACGGCT; T7_Xist_F, TAATACGACTCACTATA
GCTACTTACACCTTGGCCTC; and Xist_R, AAGTAATTTGAGTATCAT
CTGCC.
In-vitro-transcribed RNA was DNased (TURBO), TRIzol-purified, phospha-
tased (Alkaline Phosphatase, New England Biolabs), end-labeled with ATP
[g-32P], and purified through Microspin G-50 columns. RNA probe was dena-Figure 7. Jpx RNA and CTCF Titrate Each Other at the Xist Promoter I
(A) In vivo titration shown by CTCF ChIP analysis on transgenic female ES cells at
Tg(TRE:Ctcf) Dox (set to 1.0) for each site using a one-way t test (*p < 0.05
Averages ± SE.
(B) Titration and modulation of Xist P1+P2 transcription shown by luciferase assa
with luciferase constructs. Left panel: Jpx overexpression achieved by Tg(EF1a:J
abolished by mutating P2. Right panel: Transcription repression caused by ove
induced by Dox via Tg(TRE:Ctcf). At least two independent transfections andR4
Averages ± SE. *p < 0.05. **p < 0.01. (One-tail t tests in the pairwise comparison
(C) Summary of data supporting the Jpx-CTCF titration model.
(D) Model: Jpx RNA activates Xist by extricating CTCF from the Xist promoter.
(E) X:A titration: BF, blocking factor. CF, competence factor. The precise comp
component of BF. Jpx forms CF only when present in 2-fold excess.
(F) Nonlinear dynamics would be a necessary property of the titrationmodel, most
would enable small changes in factor concentration to elicit large biological effec
gray line).tured at 95C for 2 min and incubated at 50C for 5 min, 37C for 15 min, and
RT for 15 min, cooled, and maintained in folding buffer (50 mM NaCl, 2 mM
MgCl2) on ice prior to the binding reaction. Recombinant proteins were incu-
bated at room temperature with 0.5 pmol RNA probes for 30 min in 10 ml bind-
ing buffer containing 1 mg poly dI-dC, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl,
5 mM MgCl2, 0.1 mM ZnSO4, 1 mM DTT, 10% glycerol, 0.1% Tween-20,
0.1 mM polyamine, 8 U Rnase Inhibitor (Roche), and 1 mg Yeast transfer
RNA (tRNA). Samples were resolved at 4C by TBE- 5% or 6% PAGE and
imaged on BioMax film (Kodak). In DNA-RNA titration EMSA, protein was incu-
bated with DNA competitors prior to adding RNA probes. For RNA-DNA titra-
tion experiments, RNA competitors were mixed with protein and DNA probes
in RNA EMSA binding buffer, including RNase inhibitor and yeast tRNA.
Chromatin Immunoprecipitation
ChIP was performed as previously described (Blais et al., 2005), with modifica-
tions. Approximately 1.5 million ES cells were crosslinked in 1% formaldehyde
at RT for 10 min and quenched with glycine (125 mM final concentration) for
5 min at RT. Chromatin was sonicated using Bioruptor XL (Diagenode), treated
with RNase A (0.2 mg/ml) at 37C for 30 min, and 3 mg of anti-CTCF (Cell
Signaling 2899) or IgG (Cell Signaling 2729) were incubated with chromatin
at 4C overnight. Protein-antibody complexes were recovered with Dynal-
beads Protein G (Invitrogen), DNA was extracted with phenol/chloroform,
and quantitative PCR was performed using these primers:
Rnf12_F, CCCCAGGTGAAAGTACTGAGG; Rnf12_R, CTCTCCAGCTC
TATTTTCATCG; Xist_50F, CCCTACCTGAACCACCTCAATAGT; Xist_50R,
AGTTCCCTTTAGGCGTCCCAT (Navarro et al., 2006); P1_F, ACGCGTCATGT
CACTGAGC; P1_R, AAAACGTCAAAAATCTCGTGG; P2_F, CTCGACAGCC
CAATCTTTGTT; P2_R, ACCAACACTTCCACTTAGCC (Jeon and Lee, 2011);
RS14c_F, GGCTACACACAAGATGGCGTCTGTAACTTG; RS14c_R, TAGG
TTTGGGTGTTATACCCGTGTAGGC (Spencer et al., 2011); H19_F, GTCACT
CAGGCATAGCATTC; and H19_R, GTCTGCCGAGCAATATGTAG.
Allele-specific quantitative PCR at P2 was performed using primers 231_F,
TGTGCATTATTGCTTGGTGGCCAG and 371cas_R, TGCGCTCTCCCGA
CACTTC or 129_R, CATGCGCTCTCCCGACCTG.
RNA Immunoprecipitation
Crosslink RNA immunoprecipitation (RIP) was performed as previously
described (Jeon and Lee, 2011) on 107 Tg(TRE:Ctcf) ES cells differentiated
in the presence of 1 mg/ml doxycycline for 12 days. Cells were UV crosslinked
at 254 nm (200 J/cm2) in PBS, collected by scraping, and lysed in PBS supple-
mented with 0.5% NP-40, 0.5% sodium-deoxycholate, RNase inhibitor, and
proteinase inhibitor cocktail at 4C for 30 min. After 15 min at 37C with
30 U of TURBO DNase, cell debris was removed, and supernatant was used
for immunoprecipitation using Flag-agarose beads overnight at 4C. Beads
were washed three times with PBS containing 1%NP-40, 0.5% sodium-deox-
ycholate, and 300 mM NaCl and were resuspended in TURBO DNase buffer
with 10 U DNase, RNase inhibitor, and proteinase inhibitor cocktail for
30 min at 37C. Beads were further washed twice in the abovementioned
wash buffer containing 10 mM EDTA. RNA was eluted by incubating inn Vivo
d0. Enrichment values were normalized against H19 control and compared to
). At least three independent experiments were performed for each cell line.
ys in d4 female ES cells of indicated genotypes. Map of Xist’s 50 end is shown
px) in Jpx+/mutants rescues Xist promoter activity. Middle panel: Rescue is
rexpressing CTCF is relieved by mutating P2. CTCF+, CTCF overexpression
independent luciferase measurements were performed for each experiment.
indicated.)
osition of BF and its Xic binding site is currently unknown. CTCF may be a
probably effected by highly cooperative interactions. A sigmoidal binding curve
ts (e.g., all or none binding), in a way not possible with linear dynamics (broken
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proteinase K buffer (100 mM Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM EDTA,
4 mg/ml proteinase K, and RNase inhibitor) for 20 min at 37C. Elution was
continued for another 20 min after adding 7 M urea. RNA was extracted using
TRIzol LS and analyzed by qRT-PCR.
RNA Pull-Down Assay
Purified Flag-tagged CTCF and GFP proteins (200 ng or as indicated) were
incubated with 10 mg total RNA from immortalized female MEFs in binding
buffer (20 mMHEPES [pH 7.5], 150mMNaCl, 0.1%NP-40, 1 mMAEBSF, pro-
tease inhibitor cocktail, and RNase inhibitor). After 30min at 4C, Flag-agarose
beads were added for another 30 min. Beads were captured, washed twice
with binding buffer, and washed twice with wash buffer (20 mM HEPES
[pH 7.5], 350mMNaCl, 0.1%NP-40, 1mMAEBSF, protease inhibitor cocktail,
and RNase inhibitor). RNA was extracted with TRIzol, and quantitative PCR
was performed using SYBRGreen or Taqman primers. Relative abundance
of Jpx and a housekeeping mRNA, cyclophilin A, was normalized to input.
Primers are as follows: mJpx76+(ex1), mJpx225-(ex2), and mJpx339+(ex4),
GGGCTCAACAAAAGAGCAAA; mJpx607-(ex5), TGGAGTTATGGCCTCG
AAGT; CycophilinA_F, CGATGACGAGCCCTTGG; CycophilinA_R, TCTG
CTGTCTTTGGAACTTTGTC; CycophilinA_probe, FAM-CGCGTCTCCTTT
GAGCTGTTTGCA-TAMRA.
Luciferase Assay
A 1 kb NheI-PmlI fragment containing Xist P2 was cloned into pGL4.14 vector
(Promega) to make 1 Kb-Luc, and a 2 kb MluI-PmlI fragment, including Xist P1
and P2, was cloned to make 2 Kb-Luc. P2 mutation was introduced using
QuikChange Multi Site-Directed Mutagenesis Kit (Agilent). Promoterless vec-
tor plasmid pGL4.14 served as control. Dual-Glo luciferase assay (Promega)
was used with Renilla pGL4.74 as control reporter. Transient transfections
were performed using Lipofectamin 2000 (Invitrogen), with plasmids linearized
by PstI or PvuI; a 2.5 mg of luciferase construct of 1 Kb-Luc, or 2 Kb-Luc, or
promoterless vector, was cotransfected with 0.15 mg Renilla pGL4.74 using
8 ml Lipofectamin into 106 female ES cells. For overexpressing Jpx, Jpx exons
1–3were fused to the EF1a promoter in pEF1/V5-His and cotransfected into d3
female ES cells. pEF1/V5-His transfection was used as control. Jpx overex-
pression and Luciferase activity were analyzed 24–36 hr posttransfection.
For overexpressing CTCF, Tg(TRE:Ctcf) female ES cells were transfected at
d2 with Doxycycline (1 mg/ml) applied at d0. Luciferase activities were
analyzed 36 hr posttransfection. Firefly and Renilla luminescence was
measured on a TopCount NXT Luminescence Counter. Firefly/Renilla lumines-
cence ratio was normalized against the promoterless control.SUPPLEMENTAL INFORMATION
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